Trial site
The First People's Hospital of Changde City
- 13running trials
- 7closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer5 trials
- Type 2 diabetes4 trials
- Lung cancer2 trials
- Triple-negative breast cancer2 trials
- Atopic dermatitis (eczema)1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- Familial hypercholesterolaemia1 trial
- Liver cirrhosis1 trial
- Obesity1 trial
- Ovarian cancer1 trial
- Stroke1 trial
- Phase
- Phase 316 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed7 trials
- Active, not recruiting5 trials
- Not yet recruiting5 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company4 trials
- Shenzhen HighTide Biopharmaceutical Ltd.3 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 trials
- Beijing Protgen Biotechnology Development Co., Ltd.1 trial
- Biotheus Inc.1 trial
- and 9 more
Running trials
Recruiting
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Recruiting
Recruiting
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer3 recruiting
- Lung cancer1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Stroke1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis
Completed
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Completed
Completed
Completed
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026